logo

COALINDIA vs SUNPHARMA: Stock Comparison

COAL INDIA vs SUN PHARMACEUTICAL IND LUpdated 23 Oct 26, 4:08 PM ISTNSE & company filings

SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. COAL INDIA shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

COALINDIA leads 10; SUNPHARMA leads 1 of 13

Not a rating
These companies operate in different sectors (Oil Gas & Consumable Fuels vs Healthcare). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

COALINDIASUNPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹2.45 L Cr
₹4.18 L Cr
P/E RatioCOALINDIA has the lower reading
7.86x ✓
34.58x
P/B RatioCOALINDIA has the lower reading
2.06x ✓
5x
EPSCOALINDIA has the higher reading
₹14.36 ✓
₹12.06
Book ValueContext only
₹196.35
₹349.6
Dividend YieldCOALINDIA has the higher reading
6.66% ✓
0.92%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SUNPHARMA is the larger company
₹4.18 L Cr vs ₹2.45 L Cr
P/E Ratio
COALINDIA has a lower P/E
7.86x vs 34.58x
P/B Ratio
COALINDIA has a lower P/B
2.06x vs 5x
EPS
COALINDIA has higher earnings per share
₹14.36 vs ₹12.06
Dividend Yield
COALINDIA has a higher dividend yield
6.66% vs 0.92%
Revenue Growth (TTM YoY)
COALINDIA has faster revenue growth
16.2% vs 12.8%
EPS Growth (TTM YoY)
SUNPHARMA has faster EPS growth
25.6% vs 12.9%
ROE
COALINDIA has a higher ROE
91.33% vs 13.72%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCOALINDIASUNPHARMA
SectorOil Gas & Consumable FuelsHealthcare
IndustryCoalPharmaceuticals

Price

MetricCOALINDIASUNPHARMA
Live Price₹397.45₹1,748
Day Change-1.27%-0.57%
Volume46.28 L10.65 L
52-Week High₹491.25₹2,046.9
52-Week Low₹369.6₹1,583.7
Distance from 52W High-19.09%-14.6%

Valuation

MetricCOALINDIASUNPHARMA
Market Cap₹2.45 L Cr₹4.18 L Cr
P/E Ratio7.86x34.58x
P/B Ratio2.06x5x
EPS₹14.36₹12.06
Book Value₹196.35₹349.6
Dividend Yield6.66%0.92%

Growth

MetricCOALINDIASUNPHARMA
Revenue Growth (TTM YoY)16.2%12.8%
EPS Growth (TTM YoY)12.9%25.6%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricCOALINDIASUNPHARMA
ROE91.33%13.72%
ROCE90.83%15.16%
Net Margin23.83%18.56%
Operating Margin1,227.42%26.44%
Debt to Equity0.04x0.05x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricCOALINDIASUNPHARMA
Promoter Holding61.13%52.68%▼ 1.8 pp
FII Holding9.59%▼ 0.78 pp14.36%▼ 0.17 pp
DII Holding23.45%▲ 1.24 pp22.27%▲ 0.09 pp
Public Holding5.73%▼ 0.47 pp10.7%▲ 1.89 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: COAL INDIA and SUN PHARMACEUTICAL IND L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.